microRNA在炎症性皮肤病中作用的研究进展

doi:10.35541/cjd.20190864

中华皮肤科杂志 ›› 2021, Vol. 54 ›› Issue (2): 178-182.doi: 10.35541/cjd.20190864

microRNA在炎症性皮肤病中作用的研究进展

叶瑞贤薛如君梁景耀刘焕颜熊绮颖董良娇张锡宝

广州医科大学皮肤病研究所广州市皮肤病防治所皮肤科 510095

收稿日期:2019-08-29 修回日期:2020-02-05 发布日期:2021-01-29
通讯作者: 张锡宝 E-mail:zxibao@126.com
基金资助:
广东省医学科学技术研究基金（A2019464）

Role of microRNAs in inflammatory skin diseases

Ye Ruixian, Xue Rujun, Liang Jingyao, Liu Huanyan, Xiong Qiying, Dong Liangjiao, Zhang Xibao

Department of Dermatology, Institute of Dermatology, Guangzhou Medical University, Guangzhou Institute of Dermatology, Guangzhou 510095, China

Received:2019-08-29 Revised:2020-02-05 Published:2021-01-29
Contact: Zhang Xibao E-mail:zxibao@126.com
Supported by:
Medical Science and Technology Research Fund of Guangdong Province（A2019464）

摘要/Abstract

摘要： 【摘要】 microRNA（miRNA）是一类转录后调控基因表达的非编码RNA分子，参与皮肤各种病理生理过程。近年来，miRNA表达谱的变化已被报道与部分炎症性皮肤病相关，例如miR-203、miR-146a、miR-21在银屑病皮损中表达上调；miR-155、miR-146a在特应性皮炎皮损中表达上调；miR-21、miR-223、miR-142-3p、miR142-5p在过敏性接触性皮炎皮损表达上调；而miR-146a、miR-155在系统性红斑狼疮患者外周血表达下调；miR-223在皮肌炎皮损中表达下调等。本文综述miRNA与部分炎症性皮肤病发生、发展之间的联系。

关键词: 微RNAs, 炎症, 皮肤疾病

Abstract: 【Abstract】 MicroRNAs (miRNAs) are a class of non-coding RNA molecules that regulate gene expression after transcription and participate in various pathophysiological processes in the skin. In recent years, it has been reported that changes in miRNA expression profiles are related to some inflammatory skin diseases. For example, miR-203, miR-146a and miR-21 are upregulated in psoriatic lesions, miR-155 and miR-146a are upregulated in atopic dermatitis lesions, miR-21, miR-223, miR-142-3p and miR142-5p are upregulated in allergic contact dermatitis lesions; however, miR-146a and miR-155 are downregulated in peripheral blood of patients with systemic lupus erythematosus, miR-223 is downregulated in dermatomyositis lesions. This review summarizes relationships of miRNAs with the occurrence and development of some inflammatory skin diseases.

Key words: MicroRNAs, Inflammation, Skin diseases

叶瑞贤薛如君梁景耀刘焕颜熊绮颖董良娇张锡宝. microRNA在炎症性皮肤病中作用的研究进展[J]. 中华皮肤科杂志, 2021,54(2):178-182. doi:10.35541/cjd.20190864

Ye Ruixian, Xue Rujun, Liang Jingyao, Liu Huanyan, Xiong Qiying, Dong Liangjiao, Zhang Xibao. Role of microRNAs in inflammatory skin diseases[J]. Chinese Journal of Dermatology, 2021, 54(2): 178-182.doi:10.35541/cjd.20190864

参考文献 35

［1］	Deng X, Su Y, Wu H, et al. The role of microRNAs in autoimmune diseases with skin involvement［J］. Scand J Immunol, 2015,81（3）:153⁃165. doi: 10.1111/sji.12261.
［2］	Mannucci C, Casciaro M, Minciullo PL, et al. Involvement of microRNAs in skin disorders: a literature review［J］. Allergy Asthma Proc, 2017,38（1）:9⁃15. doi: 10.2500/aap.2017.38.4013.
［3］	Singhvi G, Manchanda P, Krishna Rapalli V, et al. MicroRNAs as biological regulators in skin disorders［J］. Biomed Pharmacother, 2018,108:996⁃1004. doi: 10.1016/j.biopha.2018. 09.090.
［4］	Chen JQ, Papp G, Szodoray P, et al. The role of microRNAs in the pathogenesis of autoimmune diseases［J］. Autoimmun Rev, 2016,15（12）:1171⁃1180. doi: 10.1016/j.autrev.2016.09.003.
［5］	Yi R, O′Carroll D, Pasolli HA, et al. Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs［J］. Nat Genet, 2006,38（3）:356⁃362. doi: 10.1038/ng1744.
［6］	Andl T, Murchison EP, Liu F, et al. The miRNA⁃processing enzyme dicer is essential for the morphogenesis and maintenance of hair follicles［J］. Curr Biol, 2006,16（10）:1041⁃1049. doi: 10.1016/j.cub.2006.04.005.
［7］	Jackson SJ, Zhang Z, Feng D, et al. Rapid and widespread suppression of self⁃renewal by microRNA⁃203 during epidermal differentiation［J］. Development, 2013,140（9）:1882⁃1891. doi: 10.1242/dev.089649.
［8］	Wei T, Orfanidis K, Xu N, et al. The expression of microRNA⁃203 during human skin morphogenesis［J］. Exp Dermatol, 2010,19（9）:854⁃856. doi: 10.1111/j.1600⁃0625.2010.01118.x.
［9］	Løvendorf MB, Skov L. miRNAs in inflammatory skin diseases and their clinical implications［J］. Expert Rev Clin Immunol, 2015,11（4）:467⁃477. doi: 10.1586/1744666X.2015.1020301.
［10］	Timis TL, Orasan RI. Understanding psoriasis: role of miRNAs［J］. Biomed Rep, 2018,9（5）:367⁃374. doi: 10.3892/br.2018. 1146.
［11］	Wang MJ, Xu YY, Huang RY, et al. Role of an imbalanced miRNAs axis in pathogenesis of psoriasis: novel perspectives based on review of the literature［J］. Oncotarget, 2017,8（3）:5498⁃5507. doi: 10.18632/oncotarget.12534.
［12］	Xu Y, Ji Y, Lan X, et al. miR⁃203 contributes to IL⁃17⁃induced VEGF secretion by targeting SOCS3 in keratinocytes［J］. Mol Med Rep, 2017,16（6）:8989⁃8996. doi: 10.3892/mmr.2017.7759.
［13］	Xu N, Meisgen F, Butler LM, et al. MicroRNA⁃31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40［J］. J Immunol, 2013,190（2）:678⁃688. doi: 10.4049/jimmunol.1202695.
［14］	Xu N, Brodin P, Wei T, et al. MiR⁃125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2［J］. J Invest Dermatol, 2011,131（7）:1521⁃1529. doi: 10.1038/jid.2011.55.
［15］	Meisgen F, Xu N, Wei T, et al. MiR⁃21 is up⁃regulated in psoriasis and suppresses T cell apoptosis［J］. Exp Dermatol, 2012,21（4）:312⁃314. doi: 10.1111/j.1600⁃0625.2012.01462.x.
［16］	Guinea⁃Viniegra J, Jiménez M, Schonthaler HB, et al. Targeting miR⁃21 to treat psoriasis［J］. Sci Transl Med, 2014,6（225）:225re1. doi: 10.1126/scitranslmed.3008089.
［17］	Masalha M, Sidi Y, Avni D. The contribution of feedback loops between miRNAs, cytokines and growth factors to the pathogenesis of psoriasis［J］. Exp Dermatol, 2018,27（6）:603⁃610. doi: 10.1111/exd.13520.
［18］	邓蕙妍, 林玲, 周欣, 等. 寻常型银屑病患者皮损miR⁃146a的表达及意义［J］. 中国中西医结合皮肤性病学杂志, 2016,15（3）:142⁃144. doi: 10.3969/j.issn.1672⁃0709.2016.03.004.
［19］	Park H, Huang X, Lu C, et al. MicroRNA⁃146a and microRNA⁃146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins［J］. J Biol Chem, 2015,290（5）:2831⁃2841. doi: 10.1074/jbc.M114.591420.
［20］	Xia P, Fang X, Zhang ZH, et al. Dysregulation of miRNA146a versus IRAK1 induces IL⁃17 persistence in the psoriatic skin lesions［J］. Immunol Lett, 2012,148（2）:151⁃162. doi: 10.1016/j.imlet.2012.09.004.
［21］	Sonkoly E, Janson P, Majuri ML, et al. MiR⁃155 is overexpressed in patients with atopic dermatitis and modulates T⁃cell proliferative responses by targeting cytotoxic T lymphocyte⁃associated antigen 4［J］. J Allergy Clin Immunol, 2010,126（3）:581⁃589.e1⁃20. doi: 10.1016/j.jaci.2010.05.045.
［22］	Ma L, Xue HB, Wang F, et al. MicroRNA⁃155 may be involved in the pathogenesis of atopic dermatitis by modulating the differentiation and function of T helper type 17 （Th17） cells［J］. Clin Exp Immunol, 2015,181（1）:142⁃149. doi: 10.1111/cei.12624.
［23］	Rebane A, Runnel T, Aab A, et al. MicroRNA⁃146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes［J］. J Allergy Clin Immunol, 2014,134（4）:836⁃847.e11. doi: 10.1016/j.jaci.2014.05.022.
［24］	Yang Z, Zeng B, Wang C, et al. MicroRNA⁃124 alleviates chronic skin inflammation in atopic eczema via suppressing innate immune responses in keratinocytes［J］. Cell Immunol, 2017,319:53⁃60. doi: 10.1016/j.cellimm.2017.08.003.
［25］	Vennegaard MT, Bonefeld CM, Hagedorn PH, et al. Allergic contact dermatitis induces upregulation of identical microRNAs in humans and mice［J］. Contact Dermatitis, 2012,67（5）:298⁃305. doi: 10.1111/j.1600⁃0536.2012.02083.x.
［26］	Gulati N, Løvendorf MB, Zibert JR, et al. Unique microRNAs appear at different times during the course of a delayed⁃type hypersensitivity reaction in human skin［J］. Exp Dermatol, 2015,24（12）:953⁃957. doi: 10.1111/exd.12813.
［27］	Pivarcsi A, Meisgen F, Xu N, et al. Changes in the level of serum microRNAs in patients with psoriasis after antitumour necrosis factor⁃α therapy［J］. Br J Dermatol, 2013,169（3）:563⁃570. doi: 10.1111/bjd.12381.
［28］	Løvendorf MB, Mitsui H, Zibert JR, et al. Laser capture microdissection followed by next⁃generation sequencing identifies disease⁃related microRNAs in psoriatic skin that reflect systemic microRNA changes in psoriasis［J］. Exp Dermatol, 2015,24（3）:187⁃193. doi: 10.1111/exd.12604.
［29］	Qu B, Cao J, Zhang F, et al. Type I interferon inhibition of microRNA⁃146a maturation through up⁃regulation of monocyte chemotactic protein⁃induced protein 1 in systemic lupus erythematosus［J］. Arthritis Rheumatol, 2015,67（12）:3209⁃3218. doi: 10.1002/art.39398.
［30］	Tang Y, Luo X, Cui H, et al. MicroRNA⁃146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins［J］. Arthritis Rheum, 2009,60（4）:1065⁃1075. doi: 10.1002/art.24436.
［31］	杜明, 陶李, 王昱斌, 等. SLE患者外周血单个核细胞中miR⁃148b、miR⁃152和靶基因dnmt1的表达及其临床意义［J］. 免疫学杂志, 2018,34（11）:966⁃971+983.
［32］	Lashine YA, Salah S, Aboelenein HR, et al. Correcting the expression of miRNA⁃155 represses PP2Ac and enhances the release of IL⁃2 in PBMCs of juvenile SLE patients［J］. Lupus, 2015,24（3）:240⁃247. doi: 10.1177/0961203314552117.
［33］	Mizui M, Tsokos GC. Low⁃dose IL⁃2 in the treatment of lupus［J］. Curr Rheumatol Rep, 2016,18（11）:68. doi: 10.1007/s11926⁃016⁃0617⁃5.
［34］	Inoue K, Jinnin M, Yamane K, et al. Down⁃regulation of miR⁃223 contributes to the formation of Gottron′s papules in dermatomyositis via the induction of PKCɛ［J］. Eur J Dermatol, 2013,23（2）:160⁃167. doi: 10.1684/ejd.2013.1959.
［35］	Hirai T, Ikeda K, Tsushima H, et al. Circulating plasma microRNA profiling in patients with polymyositis/dermatomyositis before and after treatment: miRNA may be associated with polymyositis/dermatomyositis［J］. Inflamm Regen, 2018,38:1. doi: 10.1186/s41232⁃017⁃0058⁃1.

[1]	胡梦瑶李敏陈思涵魏雪翠陈宇杰徐松陈旭. 角质形成细胞表达的S100A8/A9在3种常见皮肤炎症损伤模式中调控效应差异的研究[J]. 中华皮肤科杂志, 2024, 57(5): 435-444.
[2]	裴璐郑娜娜曾荣谢媛媛徐浩翔段志敏刘宇甄李岷. 痤疮丙酸杆菌生物膜诱导角质形成细胞发生炎症反应的分子机制研究[J]. 中华皮肤科杂志, 2024, 57(4): 302-308.
[3]	赵迎高翠娥隋昕宋志强. 基于高加索人单细胞转录组的炎症性树突状表皮细胞的免疫代谢研究[J]. 中华皮肤科杂志, 2024, 57(4): 343-349.
[4]	洪永镇王倩梁俊琴. 二代测序技术在非遗传性皮肤病领域中的运用[J]. 中华皮肤科杂志, 2024, 0(3): 20220436-e20220436.
[5]	魏子妤杨勇. 离子通道与玫瑰痤疮发病机制的研究进展[J]. 中华皮肤科杂志, 2024, 57(2): 174-177.
[6]	郭蕾曹春艳方晓雅冯素英. 自身免疫性大疱病患者创面感染多重耐药菌现况及危险因素分析[J]. 中华皮肤科杂志, 2024, 57(2): 155-160.
[7]	王晨薛晨红宋静卉李建国李振鲁张守民李明王建波. 阿达木单抗治疗Blau综合征1家系3例[J]. 中华皮肤科杂志, 2024, 0(2): 20220239-e20220239.
[8]	陈春里闫思聿王丹高丽华谭丽娜唐四元刘伟曾金容鲁建云. 酸化脂肪酸酯治疗特应性皮炎样模型小鼠的疗效及机制初探[J]. 中华皮肤科杂志, 2023, 56(9): 822-831.
[9]	荆可王媛李锁冯素英. 表现为环状红斑水疱的自身免疫性表皮下水疱病25例回顾性分析[J]. 中华皮肤科杂志, 2023, 56(9): 832-838.
[10]	陈耀龙刘辉姚志荣高兴华. 提升皮肤病领域指南和共识质量的策略与建议[J]. 中华皮肤科杂志, 2023, 56(9): 805-808.
[11]	孙小洁刘毅. 抗雄激素药物治疗皮肤病研究进展[J]. 中华皮肤科杂志, 2023, 56(9): 882-885.
[12]	贾韬宋相瑾耿松梅. 自身炎症性皮肤病[J]. 中华皮肤科杂志, 2023, 56(8): 794-799.
[13]	唐志铭荆梦晴陆鹭单霄张翠侠张晓宇孟飒. 犀地凉血方通过LncRNA NEAT1/miR-485-5p/ STAT3调控网络对HaCaT细胞增殖、凋亡影响的研究[J]. 中华皮肤科杂志, 2023, 56(7): 642-650.
[14]	连盼盼刘军苏忠兰王宏伟. 过氧化物酶体增殖物激活受体γ对皮肤生理功能和病理过程的影响[J]. 中华皮肤科杂志, 2023, 56(4): 365-368.
[15]	王亚玲谢红付李吉汪犇. JAK-STAT信号通路与玫瑰痤疮[J]. 中华皮肤科杂志, 2023, 56(2): 169-172.

microRNA在炎症性皮肤病中作用的研究进展

Role of microRNAs in inflammatory skin diseases

PDF

PDF (Mobile)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 35

相关文章 15

Metrics

本文评价

推荐阅读 10